Indonesia Drug Makers Seek Restrictions On India Pharma Investors
This article was originally published in PharmAsia News
Local and foreign drug makers in Indonesia are urging the government to bar new entrants, particularly Indian generics makers, from producing drugs already available in the country.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.